152 related articles for article (PubMed ID: 36891686)
1. [Expanding antiviral therapy for chronic hepatitis B: scale up screening and treatment].
Zhang MY; Sun YM; You H
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1133-1136. PubMed ID: 36891686
[TBL] [Abstract][Full Text] [Related]
2. [Expert opinion on expanding anti-HBV treatment for chronic hepatitis B].
Chinese Society of Hepatology, Chinese Medical Association
Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):131-136. PubMed ID: 35359064
[TBL] [Abstract][Full Text] [Related]
3. [Expert consensus on the clinical application of the markers of hepatitis B virus].
Cooperative Group of Basic Research and Experimental Diagnosis of Liver Diseases, Chinese Society of Hepatology, Chinese Medical Association
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):389-400. PubMed ID: 37248978
[TBL] [Abstract][Full Text] [Related]
4. [Natural history of chronic hepatitis B virus infection under low-level viremia].
Yan MM; Sun LH
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):322-326. PubMed ID: 37137862
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance and management strategies of low-level viremia during the treatment of chronic hepatitis B].
Han N; Yan LL; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1139-1143. PubMed ID: 35045626
[TBL] [Abstract][Full Text] [Related]
6. [Very low-level viremia: new clinical attention-requiring problem during the course of anti-hepatitis B virus treatment].
Shi YJ; Ding Y; Ao L; Zhang DZ; Cai DC
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1147-1150. PubMed ID: 35045628
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Associated Factors of Low-Level Viremia in Chronic Hepatitis B Patients After Long-Term Therapy with Nucleos(t)ide Analogs.
Han J; Guo Y; Zhang X; Zhang Y; Sun J; He J; Mao R; Huang Y; Zhang J
Turk J Gastroenterol; 2023 Jan; 34(1):53-61. PubMed ID: 36620929
[TBL] [Abstract][Full Text] [Related]
8. [Low-level viremia-induced liver fibrosis and hepatocellular carcinoma in chronic hepatitis B].
Lu ZZ; Sun YM; You H
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1144-1146. PubMed ID: 35045627
[TBL] [Abstract][Full Text] [Related]
9. [A possible mechanism for low-level viremia occurrence in nucleos(t)ide analog-treated chronic hepatitis B patients].
Wang LJ; Gu ZQ; Xu ZM; Chen XM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1151-1155. PubMed ID: 35045629
[TBL] [Abstract][Full Text] [Related]
10. [A new concept from a global perspective for expanding the treatment of chronic hepatitis B].
Ai XW; Zhang MY; Sun YM; You H
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):385-388. PubMed ID: 38858185
[TBL] [Abstract][Full Text] [Related]
11. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
12. [Current issues in antiviral therapy of chronic hepatitis B and C].
Bakulin IG
Eksp Klin Gastroenterol; 2010; (5):3-9. PubMed ID: 20731128
[TBL] [Abstract][Full Text] [Related]
13. [Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].
You H; Sun YM; Zhang MY; Nan YM; Xu XY; Li TS; Wang GQ; Hou JL; Duan ZP; Wei L; Wang FS; Jia JD; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):385-388. PubMed ID: 37248977
[TBL] [Abstract][Full Text] [Related]
14. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection].
Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915
[No Abstract] [Full Text] [Related]
15. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
Dai CY; Chuang WL; Huang JF; Yu ML
Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
[No Abstract] [Full Text] [Related]
16. High treatment modification rates with lamivudine therapy in HBV-infected patients with low baseline viremia and early virological response: A multicenter study.
Gonen C; Gunduz F; Doganay L; Enc FY; Yegin EG; Ahishali E; Erdem E; Sokmen M; Tuncer I; Ozdogan O
J Dig Dis; 2015 May; 16(5):286-92. PubMed ID: 25708813
[TBL] [Abstract][Full Text] [Related]
17. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.
Juday T; Tang H; Harris M; Powers AZ; Kim E; Hanna GJ
J Gen Intern Med; 2011 Mar; 26(3):239-44. PubMed ID: 20978862
[TBL] [Abstract][Full Text] [Related]
18. [Expanding antiviral indications for chronic hepatitis B using the concept of chronic disease health management: act again!].
Sun LH; Shaniya N; Xu Q; Pan KJ; Bao YXM; Han D; Zhang J
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):1002-1003. PubMed ID: 37872098
[No Abstract] [Full Text] [Related]
19. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
Hwang JP; Feld JJ; Hammond SP; Wang SH; Alston-Johnson DE; Cryer DR; Hershman DL; Loehrer AP; Sabichi AL; Symington BE; Terrault N; Wong ML; Somerfield MR; Artz AS
J Clin Oncol; 2020 Nov; 38(31):3698-3715. PubMed ID: 32716741
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Okada M; Enomoto M; Kawada N; Nguyen MH
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1095-1104. PubMed ID: 28752768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
